No significant differences seen for remission of type 2 diabetes, dyslipidemia, obstructive sleep apnea, or prevalence of Barrett esophagus
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, June 24, 2022 (HealthDay News) -- Long-term outcomes are similar after laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYGB) in patients with severe obesity, according to a study published online June 22 in JAMA Surgery.
Paulina Salminen, M.D., Ph.D., from Turku University in Finland, and colleagues compared 10-year outcomes of weight loss and remission of obesity-related comorbidities and the prevalence of gastroesophageal reflux symptoms, endoscopic esophagitis, and Barrett esophagus (BE) after LSG and LRYGB. The analysis included 240 patients (aged 18 to 60 years) randomly assigned to LSG (121 patients) or LRYGB (119 patients).
The researchers found that the median percentage excess weight loss was 43.5 percent after LSG and 50.7 percent after LRYGB, with the mean estimate percentage excess weight loss higher in LRYGB (8.4 percent). There was no statistically significant difference seen between the procedures for type 2 diabetes remission, dyslipidemia, or obstructive sleep apnea. Following LRYGB, hypertension remission was superior. After LSG, esophagitis was more prevalent, but there were no significant differences for BE. The reoperation rate was similar between the groups.
"Both procedures resulted in good and sustainable weight loss at 10 years," the authors write.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Published on June 24, 2022
Read this Next
Other Trending Articles